The Ome-Ome | GenomeWeb

The Ome-Ome

In recent years the "omics" business has begun treading dangerously close to New York Times Styles section territory. Just as three people doing something you've never heard of before is enough to make for a "trend", it seems these days any collection of a dozen or so data points qualifies as an "ome."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.